Washington, D.C. 20549


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 10, 2016

Cigna Corporation
(Exact name of registrant as specified in its charter)

(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)

900 Cottage Grove Road
Bloomfield, Connecticut 06002
(Address of principal executive offices)  (Zip Code)

Registrant's telephone number, including area code:

(860) 226-6000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 10, 2016, Herbert A. Fritch, President, Cigna-HealthSpring of Cigna Corporation (the "Company"), notified the Company of his intention to retire from his position effective November 11, 2016.  Mr. Fritch will serve in an advisory role to the Company from his retirement date through December 2017.

The terms of any retirement arrangement and advisory agreement between the Company and Mr. Fritch will be disclosed on a Form 8-K as required.

Item 7.01              Regulation FD Disclosure.

M. Shawn Morris, currently Chief Operating Officer for Cigna-HealthSpring, will serve as Interim President, Cigna-HealthSpring upon Mr. Fritch's retirement.  Mr. Morris joined HealthSpring, Inc. in 2005, and held multiple leadership roles, including Executive Vice President, before Cigna's acquisition in 2012.

The information in this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this report, except as shall be expressly set forth by specific reference in such a filing.




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cigna Corporation
Date:  October 11, 2016
/s/ Nicole S. Jones
Nicole S. Jones
Executive Vice President
and General Counsel